NEW YORK, July 30, 2024 /PRNewswire/ — Omnicom (NYSE: OMC) today announced the pricing of its public offering of $600 million aggregate principal amount of 5.300% Senior Notes due 2034 (the “Notes”). The Notes will mature on November 1, 2034. The transaction is expected to close on…
Month: July 2024
OMNICOM PRICES $600 MILLION SENIOR NOTES OFFERING
NEW YORK, July 30, 2024 /PRNewswire/ — Omnicom (NYSE: OMC) today announced the pricing of its public offering of $600 million aggregate principal amount of 5.300% Senior Notes due 2034 (the “Notes”). The Notes will mature on November 1, 2034. The transaction is expected to close on…
Oddity Tech Ltd. Sued for Securities Law Violations – Contact The Rosen Law Firm Before September 17, 2024 to Discuss Your Rights – ODD
NEW YORK, July 30, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Oddity Tech Ltd. (NASDAQ: ODD) between July 19, 2023 and May 20, 2024, both dates inclusive (the “Class Period”), of the important September 17, 2024 lead…
Oddity Tech Ltd. Sued for Securities Law Violations – Contact The Rosen Law Firm Before September 17, 2024 to Discuss Your Rights – ODD
NEW YORK, July 30, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Oddity Tech Ltd. (NASDAQ: ODD) between July 19, 2023 and May 20, 2024, both dates inclusive (the “Class Period”), of the important September 17, 2024 lead…
BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, July 30, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021 and May 14, 2024, both dates inclusive (the “Class Period”), of the important September 3,…
BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, July 30, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021 and May 14, 2024, both dates inclusive (the “Class Period”), of the important September 3,…
Dell & Dean, PLLC Notification of Data Security Incident
GARDEN CITY, N.Y., July 30, 2024 /PRNewswire/ — Dell & Dean, PLLC (“Dell & Dean”) announced today that it has taken action after learning of a data security incident which may have compromised the personal information of certain individuals with information maintained on its systems….
Dell & Dean, PLLC Notification of Data Security Incident
GARDEN CITY, N.Y., July 30, 2024 /PRNewswire/ — Dell & Dean, PLLC (“Dell & Dean”) announced today that it has taken action after learning of a data security incident which may have compromised the personal information of certain individuals with information maintained on its systems….
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet regimen approved in the U.S. for patients with newly diagnosed multiple myeloma who are transplant-eligible
Findings from first-ever quadruplet therapy study with subcutaneous DARZALEX FASPRO® showed 60 percent reduction in risk of disease progression or death New regimen solidifies DARZALEX FASPRO® as a foundational frontline therapy in multiple myeloma with potential to significantly delay…
Shanghai Electric accélère le développement de la chaîne énergétique de l’hydrogène et stimule l’adoption des énergies propres
Shanghai Electric se concentre sur l’intégration de l’éolien, du solaire, du stockage et de l’hydrogène, une stratégie clé pour développer les applications d’énergie propre à l’avenir. SHANGHAI, 31 juillet 2024 /PRNewswire/ — Shanghai Electric (la « Société ») (SEHK:2727, SSE:601727) a…
